Supernus Pharmaceuticals Net Cash Flow 2011-2024 | SUPN
Supernus Pharmaceuticals net cash flow from 2011 to 2024. Net cash flow can be defined as the total change in cash for the company over the given period.
Supernus Pharmaceuticals Annual Net Cash Flow
(Millions of US $) |
| 2024 |
$-6 |
| 2023 |
$-18 |
| 2022 |
$-110 |
| 2021 |
$-85 |
| 2020 |
$107 |
| 2019 |
$-11 |
| 2018 |
$92 |
| 2017 |
$34 |
| 2016 |
$33 |
| 2015 |
$-3 |
| 2014 |
$3 |
| 2013 |
$-7 |
| 2012 |
$-8 |
| 2011 |
$25 |
| 2010 |
$-8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.813B |
$0.662B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
